Novel treatment of Hori's nevus: A combination of fractional nonablative 2,940-nm Er:YAG and low-fluence 1,064-nm Q-switched Nd:YAG laser
- PMID: 26865788
- PMCID: PMC4728905
- DOI: 10.4103/0974-2077.172198
Novel treatment of Hori's nevus: A combination of fractional nonablative 2,940-nm Er:YAG and low-fluence 1,064-nm Q-switched Nd:YAG laser
Abstract
Objective: To demonstrate a combination laser therapy to treat Hori's nevus.
Design: A prospective study.
Setting: A Singapore-based clinic.
Participants: Five female patients, aged 30-46 years, with bilateral malar Hori's nevus.
Measurements: Photographs were taken before treatment and 1 month after laser treatment was completed. These were graded by three independent physicians. The patients were also asked to grade their treatment response subjectively. They were followed up for a total of 3 months after laser treatment to monitor recurrence.
Materials and methods: The fractional nonablative 2,940-nm Er:YAG laser with a fluence of 0.7 J/cm(2), spot size 12 mm, and frequency 15 Hz was used to perform a full-face single-pass treatment. Subsequently, a second pass and third pass over Hori's nevi were done bilaterally till the clinical endpoint of skin whitening. The 1,064-nm Q-switched (QS) Nd:YAG at a fluence of 2.0 J/cm(2), frequency 2 Hz, and 4-mm spot size was used to deliver multiple passes over Hori's nevus till erythema with mild petechiae appeared. We repeated the treatment once a week for 3 more consecutive weeks.
Results: All five patients had above 80% improvement in their pigmentation and two (skin type III) achieved complete 100% clearance. Based on the patients' subjective assessments, all five of them expressed satisfaction and felt that their pigmentation had improved. There were no complications noted.
Conclusion: The fractional nonablative 2940 nm Er:YAG laser and Q-switched 1064nm laser Nd:YAG combination is an effective and safe treatment for Hori's nevus.
Keywords: Hori's nevus; Q-switched Nd:YAG laser; combination laser; facial pigmentation; nonablative Er:YAG laser.
Figures
Similar articles
-
Treatment of acquired bilateral nevus of ota-like macules (Hori's nevus) with a combination of the 532 nm Q-Switched Nd:YAG laser followed by the 1,064 nm Q-switched Nd:YAG is more effective: prospective study.Dermatol Surg. 2006 Jan;32(1):34-40. Dermatol Surg. 2006. PMID: 16393596 Clinical Trial.
-
Treatment of Hori's nevus with the Q-switched Nd:YAG laser.Dermatol Surg. 2000 May;26(5):477-80. doi: 10.1046/j.1524-4725.2000.99305.x. Dermatol Surg. 2000. PMID: 10816238
-
Efficacy and safety of 755 nm Q-switched Alexandrite Laser for Hori's nevus: a retrospective analysis of 482 Chinese women.Lasers Med Sci. 2022 Feb;37(1):345-351. doi: 10.1007/s10103-021-03257-6. Epub 2021 Apr 8. Lasers Med Sci. 2022. PMID: 33834379
-
Therapeutic options for management of Hori's nevus: A systematic review.Dermatol Ther. 2020 Jan;33(1):e13167. doi: 10.1111/dth.13167. Epub 2019 Dec 3. Dermatol Ther. 2020. PMID: 31714651
-
Optimizing Q-switched lasers for melasma and acquired dermal melanoses.Indian J Dermatol Venereol Leprol. 2019 Jan-Feb;85(1):10-17. doi: 10.4103/ijdvl.IJDVL_1086_16. Indian J Dermatol Venereol Leprol. 2019. PMID: 30027914 Review.
References
-
- Hori Y, Kawashima M, Oohara K, Kukita A. Acquired, bilateral nevus of Ota-like macules. J Am Acad Dermatol. 1984;10:961–4. - PubMed
-
- Hori Y, Takayama O. Circumscribed dermal melanoses. Classification and histologic features. Dermatol Clin. 1988;6:315–26. - PubMed
-
- Kukita A, Hori Y, Ohhara K, Kawashima M, Takehara K. Nevus of ota. In: Fitzpatrick TB, Kukita A, Morikawa F, Seiji M, Sober AJ, Toda K, editors. Biology and Diseases of Dermal Pigmentation. 1st ed. Vol. 1. Tokyo: University of Tokyo Press; 1981. pp. 67–76.
-
- Hori Y, Ohara K, Niimura M, Kukita A. Electron microscopy. Ultrastructural observations of the extracellular sheath of dermal melanocytes in the nevus of Ota. Am J Dermatopathol. 1982;4:245–51. - PubMed
-
- Sun CC, Lü YC, Lee EF, Nakagawa H. Naevus fusco-caeruleus zygomaticus. Br J Dermatol. 1987;117:545–53. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources